Table 1 Baseline characteristics for the 38 healthy subjects participating in the 12 week intervention 1
| Â | Grazing ( n=20) | Conventional ( n=18) |
|---|---|---|
Women, (n, %) | 13, 65% | 10, 55.6% |
Age, (y) | 61.9 ± 4.9 (52–69) | 60.7 ± 5.9 (50–69) |
Height, (cm) | 170.5 ± 8.4 (158–187) | 173.2 ± 7.5 (159.8-188) |
Weight, (kg) | 73.6 ± 8.4 (56.3-93) | 79.9 ± 15.5 (61.35-122.6) |
BMI, (kg/m2) | 25.4 ± 2.7 (20.81- 30.55) | 26.5 ± 3.6 (21.22-34.69) |
Total cholesterol, (mmol/L) | 5.8 ± 1.15 (3.95-7.53) | 5.5 ± 0.86 (3.98-7) |
LDL cholesterol, (mmol/L) | 3.3 ± 0.83 (1.46-4.53) | 3.3 ± 0.59 (2.45-4.21) |
HDL cholesterol, (mmol/L) | 1.5 ± 0.29 (1.02-2.06) | 1.3 ± 0.31 (0.75-1.73) |
Triacylglycerol, (mmol/L) | 1.2 ± 0.46 (0.76-2.62) | 1.3 ±0.59 (0.73-2.74) |
hsCRP, (mg/L) | 1.2 ± 1.46 (0.05-5.42) | 1.0 ± 0.93 (0.05-3.11) |
Insulin, (pmol/L) | 30.6 ± 20.05 (7.2-90.75) | 41.4 ± 35.04 (7.2-127) |
C-peptide, (pmol/L) | 566.2 ± 224.03 (349.5-1065.5) | 611.8 ± 287.82 (298–1299.5) |
Glucose, (mmol/L) | 5.6 ± 0.51 (5.02-7.14) | 5.7 ± 0.47 (5.14-6.57) |
Phytanic acid, (μM) | 3.0 ± 0.69 (1.98-4.76) | 3.0 ± 0.61 (2.3-4.28) |